DBV Technologies | Passività Correnti



Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
DBV Technologies USD 40.38M 9.25M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Incyte USD 1.28B 608.18M 2025-06
Insmed USD 239.23M 58.29M 2025-03
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
United Therapeutics USD 527.1M 194.4M 2025-06


DBV Technologies Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.